| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
39,508 |
36,510 |
$3.47M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,929 |
30,658 |
$2.86M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,031 |
12,452 |
$1.22M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,062 |
4,572 |
$821K |
| 80053 |
Comprehensive metabolic panel |
36,932 |
31,141 |
$647K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
10,955 |
9,060 |
$533K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,460 |
1,319 |
$261K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,008 |
1,815 |
$253K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,869 |
2,714 |
$245K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,273 |
5,514 |
$207K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,455 |
1,007 |
$136K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,535 |
1,402 |
$121K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,120 |
2,781 |
$91K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,301 |
2,032 |
$72K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,731 |
3,783 |
$68K |
| 87631 |
|
2,766 |
2,567 |
$59K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
925 |
831 |
$53K |
| G0378 |
Hospital observation service, per hour |
8,915 |
3,734 |
$50K |
| 87088 |
|
4,995 |
4,513 |
$49K |
| 36415 |
Collection of venous blood by venipuncture |
31,729 |
25,404 |
$43K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
915 |
854 |
$40K |
| 87430 |
|
1,745 |
1,640 |
$39K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,396 |
3,821 |
$39K |
| 84703 |
|
9,261 |
8,185 |
$39K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,218 |
1,882 |
$35K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,608 |
6,532 |
$34K |
| 81003 |
|
15,972 |
14,226 |
$33K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,460 |
1,292 |
$33K |
| 71046 |
Radiologic examination, chest; 2 views |
4,497 |
4,169 |
$31K |
| 71045 |
Radiologic examination, chest; single view |
18,607 |
16,498 |
$31K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,535 |
3,304 |
$31K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,198 |
896 |
$28K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
10,779 |
10,045 |
$26K |
| 84702 |
|
3,474 |
2,886 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,598 |
12,877 |
$25K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
17,203 |
14,260 |
$24K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,546 |
1,439 |
$23K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,829 |
2,381 |
$23K |
| 73562 |
|
1,514 |
1,298 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,725 |
1,282 |
$19K |
| 82948 |
|
3,594 |
1,894 |
$18K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,018 |
2,512 |
$18K |
| 73610 |
|
1,126 |
993 |
$17K |
| 87210 |
|
3,967 |
3,661 |
$17K |
| 73130 |
|
1,076 |
934 |
$17K |
| 73630 |
|
1,350 |
1,231 |
$16K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,448 |
634 |
$16K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
179 |
159 |
$15K |
| 87081 |
|
2,202 |
2,068 |
$14K |
| 97597 |
|
188 |
81 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
848 |
727 |
$14K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,256 |
1,058 |
$14K |
| 76801 |
|
1,952 |
1,580 |
$13K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,794 |
2,198 |
$13K |
| 73030 |
|
1,119 |
969 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,649 |
4,747 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,342 |
7,677 |
$12K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,031 |
1,777 |
$11K |
| 81025 |
|
9,277 |
8,551 |
$11K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,660 |
1,397 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
34,878 |
29,773 |
$11K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,006 |
941 |
$11K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
939 |
837 |
$10K |
| 96376 |
|
2,828 |
1,884 |
$10K |
| 72131 |
|
1,603 |
1,408 |
$10K |
| 87420 |
|
385 |
373 |
$10K |
| J1644 |
Injection, heparin sodium, per 1000 units |
297 |
135 |
$9K |
| 73110 |
|
564 |
515 |
$9K |
| 97161 |
|
337 |
304 |
$9K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
414 |
338 |
$8K |
| 93971 |
|
850 |
768 |
$8K |
| 93017 |
|
376 |
340 |
$8K |
| 97535 |
Self-care/home management training, each 15 minutes |
352 |
220 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
876 |
820 |
$8K |
| 83735 |
|
10,521 |
8,685 |
$8K |
| 76830 |
Ultrasound, transvaginal |
1,342 |
1,247 |
$7K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,622 |
2,083 |
$7K |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
388 |
310 |
$7K |
| 87077 |
|
1,071 |
966 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,685 |
5,264 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
326 |
153 |
$7K |
| 70486 |
|
454 |
414 |
$7K |
| 86900 |
|
1,928 |
1,730 |
$6K |
| 84484 |
|
15,487 |
12,149 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,660 |
5,240 |
$6K |
| 90715 |
|
361 |
332 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
998 |
870 |
$6K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
312 |
270 |
$6K |
| 85027 |
|
6,587 |
5,396 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,755 |
1,587 |
$6K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,135 |
1,744 |
$5K |
| J3490 |
Unclassified drugs |
692 |
548 |
$5K |
| 74018 |
|
534 |
503 |
$5K |
| 82962 |
|
2,074 |
1,108 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
470 |
270 |
$5K |
| 81001 |
|
11,671 |
10,541 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
463 |
333 |
$5K |
| 70491 |
|
15 |
14 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
390 |
336 |
$5K |
| 92587 |
|
63 |
59 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,067 |
1,850 |
$3K |
| J2060 |
Injection, lorazepam, 2 mg |
354 |
272 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,185 |
2,806 |
$3K |
| 85730 |
|
3,444 |
2,979 |
$3K |
| 85610 |
|
3,644 |
3,104 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
27 |
27 |
$3K |
| 83690 |
|
10,222 |
9,031 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
13 |
13 |
$2K |
| 83880 |
|
2,944 |
2,492 |
$2K |
| 82550 |
|
3,873 |
3,263 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
237 |
223 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
738 |
618 |
$2K |
| 73090 |
|
193 |
168 |
$2K |
| 87207 |
|
123 |
119 |
$2K |
| 85379 |
|
2,862 |
2,611 |
$2K |
| 73590 |
|
332 |
289 |
$2K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,468 |
1,282 |
$2K |
| 10061 |
|
85 |
73 |
$2K |
| 80061 |
Lipid panel |
2,725 |
2,386 |
$1K |
| 73140 |
|
25 |
25 |
$1K |
| 73080 |
|
110 |
100 |
$1K |
| 87158 |
|
725 |
650 |
$1K |
| 84439 |
|
1,114 |
997 |
$1K |
| 86901 |
|
1,904 |
1,706 |
$1K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
39 |
26 |
$914.72 |
| 73552 |
|
101 |
94 |
$888.14 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
18 |
18 |
$758.44 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
325 |
240 |
$747.92 |
| 87186 |
|
1,819 |
1,635 |
$662.40 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,065 |
1,801 |
$650.71 |
| 72128 |
|
433 |
370 |
$647.79 |
| 80320 |
|
776 |
629 |
$639.73 |
| 29125 |
|
40 |
39 |
$592.19 |
| 12001 |
|
29 |
29 |
$555.53 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
62 |
56 |
$520.29 |
| 85018 |
|
12 |
12 |
$491.36 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
347 |
335 |
$453.43 |
| 12011 |
|
58 |
53 |
$410.05 |
| 86850 |
|
474 |
413 |
$355.91 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
240 |
68 |
$340.74 |
| 93970 |
|
30 |
24 |
$318.82 |
| 87641 |
|
25 |
24 |
$266.86 |
| 82274 |
|
57 |
42 |
$260.52 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,658 |
2,528 |
$237.77 |
| 99218 |
|
173 |
88 |
$231.68 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
14 |
12 |
$227.88 |
| 72170 |
|
13 |
12 |
$209.64 |
| 86308 |
|
56 |
54 |
$198.64 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
537 |
529 |
$167.62 |
| 80329 |
|
236 |
210 |
$161.83 |
| 87040 |
|
232 |
205 |
$136.69 |
| 71250 |
|
16 |
14 |
$113.24 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
32 |
26 |
$102.54 |
| 72100 |
|
25 |
25 |
$97.45 |
| 81015 |
|
107 |
99 |
$92.57 |
| 85652 |
|
237 |
204 |
$92.07 |
| 82607 |
|
191 |
152 |
$68.03 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
494 |
454 |
$62.71 |
| 82728 |
|
116 |
84 |
$62.38 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
51 |
48 |
$55.96 |
| 83605 |
|
728 |
603 |
$34.49 |
| 83550 |
|
89 |
70 |
$28.18 |
| 83540 |
|
107 |
84 |
$23.17 |
| 85045 |
|
16 |
13 |
$18.69 |
| 86140 |
|
67 |
56 |
$16.97 |
| 82746 |
|
53 |
41 |
$7.84 |
| 87220 |
|
2,095 |
1,963 |
$7.43 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
235 |
216 |
$3.35 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
286 |
245 |
$2.18 |
| 87660 |
|
39 |
38 |
$0.00 |
| 87481 |
|
239 |
228 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
45 |
41 |
$0.00 |
| 85007 |
|
226 |
198 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
15 |
12 |
$0.00 |
| 82570 |
|
13 |
12 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
17 |
14 |
$0.00 |
| 82272 |
|
14 |
13 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
15 |
15 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
16 |
14 |
$0.00 |
| 87480 |
|
39 |
38 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
102 |
96 |
$0.00 |
| 73060 |
|
13 |
12 |
$0.00 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
17 |
16 |
$0.00 |
| 73502 |
|
14 |
12 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
238 |
228 |
$0.00 |
| 87486 |
|
14 |
12 |
$0.00 |
| 84132 |
|
52 |
43 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
204 |
184 |
$0.00 |
| 87510 |
|
39 |
38 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
40 |
36 |
$0.00 |
| 87581 |
|
14 |
12 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
24 |
24 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
17 |
15 |
$0.00 |
| 87070 |
|
15 |
12 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
13 |
12 |
$0.00 |
| 0352U |
|
41 |
41 |
$0.00 |
| 82553 |
|
36 |
24 |
$0.00 |
| 85651 |
|
12 |
12 |
$0.00 |